Archive 2000

• Exhibition
• Press release
• General information

News		Date
GPC Biotech Awarded DM 2,5 Million EUREKA Research Grant to Discover Novel Anti-Cancer Drug Targets GPC Biotech AG (Neuer Markt Frankfurt: GPC), a leading genomics- and proteomics-based drug discovery company, today announced that it has been awarded a DM 2.5 million (US$ 1.1 million) research grant from the BMBF (German Federal Ministry of Research) under the EUREKA research initiative (E! 2370 Cancer Circuitry). During the 3 year EUREKA project, GPC Biotech and its research partner Eurogentec SA (Seraing, Belgium) will develop innovative approaches to mapping disease signaling pathways of major types of human cancer. read more >>		December 2000
Cepheid Announces Distribution Agreement with Eurogentec for Europe Cepheid today announced that they have signed a multi-year agreement with Eurogentec to market the Cepheid Smart Cycler system in the life sciences research market in Europe. read more >>		December 2000
Eurogentecs results for 1999/2000: further strengthening Eurogentec, an important Belgian company providing research and development services in the field of Genomics, posted a consolidated turnover of BEF 716 million at the end of the 1999/2000 financial year . Its operating cash flow (EBITDA) reached BEF 113 million, whereas consolidated profits stand at BEF 60 million. The RoE is 25%. read more >>		June 2000